PROVENGE: payments to doctors
Payments that named PROVENGE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.3M
- Providers
- 9,794
- Transactions
- 56,598
- Average per transaction
- $76
The per-transaction average — $76 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 9,794 providers the average total is $441, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Dendreon Pharmaceuticals LLC | $4,319,800 | 100.0% |